New fertility drug matches standard in egg retrieval for chinese women

NCT ID NCT06173869

First seen Feb 16, 2026 · Last updated May 16, 2026 · Updated 13 times

Summary

This study tested two different starting doses of the fertility drug follitropin delta against two doses of the standard drug Gonal-F in 301 Chinese women undergoing IVF. The main goal was to see how many eggs were retrieved. The trial was completed and aimed to find the best starting dose for better IVF outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ferring Investigational Site

    Shushan, Anhui, 230032, China

  • Ferring Investigational Site

    Yuzhong, Chongqing Municipality, 401147, China

  • Ferring Investigational Site

    Guangzhou, Guandong, 510120, China

  • Ferring Investigational Site

    Guangzhou, Guangdong, 510000, China

  • Ferring Investigational Site

    Zhengzhou, Henan, China

  • Ferring Investigational Site

    Nanchang, Jiangxi, 330038, China

  • Ferring Investigational Site

    Shengyang, Liaoling, 110004, China

  • Ferring Investigational Site

    Shanghai, Shanghai Municipality, 201204, China

  • Ferring Investigational Site

    Chengdu, Sichuang, 610041, China

  • Ferring Investigational Site

    Tianjin, Tianjin Municipality, 300052, China

  • Ferring Investigational Site

    Xiaobailou, Tianjin Municipality, 300052, China

Conditions

Explore the condition pages connected to this study.